The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Substantial Differences in Specificity of HIV-Specific Cytotoxic T Cells in Acute and Chronic HIV Infection
Open accessAbstract
Cytotoxic T lymphocytes (CTLs) play a vital part in controlling viral replication during human viral infections. Most studies in human infections have focused on CTL specificities in chronic infection and few data exist regarding the specificity of the initial CTL response induced in acute infection. In this study, HIV-1 infection in persons expressing human histocompatibility leukocyte antigen (HLA)-A*0201 was used as a means of addressing this issue. In chronic infection, the dominant HLA-A*0201–restricted CTL response is directed towards the epitope SLYNTVATL (“SL9”) in p17 Gag (residues 77–85). This epitope is targeted by 75% of HLA-A*0201–positive adults, and the magnitude of this A*0201-SL9 response shows a strong negative association with viral load in progressive infection. Despite using the highly sensitive peptide–major histocompatibility complex tetramer and intracellular cytokine assays, responses to the SL9 epitope were not detectable in any of 11 HLA-A*0201–positive subjects with acute HIV-1 infection (P = 2 × 10−6), even when assays were repeated using the SL9 peptide variant that was encoded by their autologous virus. In contrast, multiple responses (median 3) to other epitopes were evident in 7 of the 11 A*0201–positive subjects. Longitudinal study of two subjects confirmed that the A*0201-SL9 response emerged later than other CTL responses, and after viral set point had been reached. Together, these data show that the CTL responses that are present and that even may dominate in chronic infection may differ substantially from those that constitute the initial antiviral CTL response. This finding is an important consideration in vaccine design and in the evaluation of vaccine candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Phenotypic Analysis of Antigen-Specific T Lymphocytes
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., Barouch, D. H., McHeyzer-Williams, M. G., Bell, J. I., McMichael, A. J., & Davis, M. M. (1996) · Science · doi:10.1126/science.274.5284.94 · Cited by 3,544
Self-citationPrognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma
Mellors, J. W., Rinaldo, C. R., Gupta, P., White, R. M., Todd, J. A., & Kingsley, L. A. (1996) · Science · doi:10.1126/science.272.5265.1167 · Cited by 2,660
Koup, R. A., Safrit, J. T., Cao, Y., Andrews, C. A., McLeod, G., Borkowsky, W., Farthing, C., & Ho, D. D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4650-4655.1994 · Cited by 2,495
Control of Viremia in Simian Immunodeficiency Virus Infection by CD8 + Lymphocytes
Schmitz, J. E., Kuroda, M. J., Santra, S., Sasseville, V. G., Simon, M. A., Lifton, M. A., Racz, P., Tenner-Racz, K., Dalesandro, M., Scallon, B. J., et al. (1999) · Science · doi:10.1126/science.283.5403.857 · Cited by 2,187
Viral Immune Evasion Due to Persistence of Activated T Cells Without Effector Function
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., Sourdive, D. J. D., Suresh, M., Altman, J. D., & Ahmed, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.12.2205 · Cited by 1,978
Borrow, P., Lewicki, H., Hahn, B. H., Shaw, G. M., & Oldstone, M. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.9.6103-6110.1994 · Cited by 1,882
Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of Viremia
Rosenberg, E. S., Billingsley, J. M., Caliendo, A. M., Boswell, S. L., Sax, P. E., Kalams, S. A., & Walker, B. D. (1997) · Science · doi:10.1126/science.278.5342.1447 · Cited by 1,835
Self-citationJin, X., Bauer, D. E., Tuttleton, S. E., Lewin, S., Gettie, A., Blanchard, J., Irwin, C. E., Safrit, J. T., Mittler, J., Weinberger, L., et al. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.6.991 · Cited by 1,407
Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA
Ogg, G. S., Jin, X., Bonhoeffer, S., Dunbar, P. R., Nowak, M. A., Monard, S., Segal, J. P., Cao, Y., Rowland-Jones, S. L., Cerundolo, V., et al. (1998) · Science · doi:10.1126/science.279.5359.2103 · Cited by 1,383
Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus
Lechner, F., Wong, D. K. H., Dunbar, P. R., Chapman, R., Chung, R. T., Dohrenwend, P., Robbins, G., Phillips, R., Klenerman, P., & Walker, B. D. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.9.1499 · Cited by 1,269
Self-citationHLA and HIV-1: Heterozygote Advantage and B*35-Cw*04 Disadvantage
Carrington, M., Nelson, G. W., Martin, M. P., Kissner, T., Vlahov, D., Goedert, J. J., Kaslow, R., Buchbinder, S., Hoots, K., & O'Brien, S. J. (1999) · Science · doi:10.1126/science.283.5408.1748 · Cited by 1,224
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
Riddell, S. R., Watanabe, K. S., Goodrich, J. M., Li, C. R., Agha, M. E., & Greenberg, P. D. (1992) · Science · doi:10.1126/science.1352912 · Cited by 1,201
Characterization of Peptides Bound to the Class I MHC Molecule HLA-A2.1 by Mass Spectrometry
Hunt, D. F., Henderson, R. A., Shabanowitz, J., Sakaguchi, K., Michel, H., Sevilir, N., Cox, A. L., Appella, E., & Engelhard, V. H. (1992) · Science · doi:10.1126/science.1546328 · Cited by 1,198
Borrow, P., Lewicki, H., Wei, X., Horwitz, M. S., Peffer, N., Meyers, H., Nelson, J. A., Gairin, J. E., Hahn, B. H., Oldstone, M. B. A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-205 · Cited by 1,183
Goulder, P. J. R., Phillips, R. E., Colbert, R. A., McAdam, S., Ogg, G., Nowak, M. A., Giangrande, P., Luzzi, G., Morgana, B., Edwards, A., et al. (1997) · Nature Medicine · doi:10.1038/nm0297-212 · Cited by 1,116
Self-citationImmune control of HIV-1 after early treatment of acute infection
Rosenberg, E. S., Altfeld, M., Poon, S. H., Phillips, M. N., Wilkes, B. M., Eldridge, R. L., Robbins, G. K., D'Aquila, R. T., Goulder, P. J. R., & Walker, B. D. (2000) · Nature · doi:10.1038/35035103 · Cited by 1,002
Self-citationBunce, M., O'Neill, C. M., Barnardo, M. C. N. M., Krausa, P., Browning, M. J., Morris, P. J., & Welsh, K. I. (1995) · Tissue Antigens · doi:10.1111/j.1399-0039.1995.tb03127.x · Cited by 997
Self-citationMigueles, S. A., Sabbaghian, M. S., Shupert, W. L., Bettinotti, M. P., Marincola, F. M., Martino, L., Hallahan, C. W., Selig, S. M., Schwartz, D., Sullivan, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.050567397 · Cited by 995
Kaslow, R. A., Carrington, M., Apple, R., Park, L., Muñoz, A., Saah, A. J., Goedert, J. J., Winkler, C., O'Brien, S. J., Rinaldo, C., et al. (1996) · Nature Medicine · doi:10.1038/nm0496-405 · Cited by 970
IMMUNODOMINANCE IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I–RESTRICTED T LYMPHOCYTE RESPONSES
Yewdell, J. W., & Bennink, J. R. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.51 · Cited by 944
Callan, M. F. C., Tan, L., Annels, N., Ogg, G. S., Wilson, J. D. K., O'Callaghan, C. A., Steven, N., McMichael, A. J., & Rickinson, A. B. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1395 · Cited by 892
Sette, A., Vitiello, A., Reherman, B., Fowler, P., Nayersina, R., Kast, W. M., Melief, C. J. M., Oseroff, C., Yuan, L., Ruppert, J., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5586 · Cited by 830
Analysis of a Successful Immune Response against Hepatitis C Virus
Cooper, S., Erickson, A. L., Adams, E. J., Kansopon, J., Weiner, A. J., Chien, D. Y., Houghton, M., Parham, P., & Walker, C. M. (1999) · Immunity · doi:10.1016/s1074-7613(00)80044-8 · Cited by 814
HIV-specific cytotoxic T lymphocytes in seropositive individuals
Walker, B. D., Chakrabarti, S., Moss, B., Paradis, T. J., Flynn, T., Durno, A. G., Blumberg, R. S., Kaplan, J. C., Hirsch, M. S., & Schooley, R. T. (1987) · Nature · doi:10.1038/328345a0 · Cited by 784
Self-citationDirect Observation of Vortex Dynamics in Superconducting Films with Regular Arrays of Defects
Harada, K., Kamimura, O., Kasai, H., Matsuda, T., Tonomura, A., & Moshchalkov, V. V. (1996) · Science · doi:10.1126/science.274.5290.1167 · Cited by 778
Gallimore, A., Glithero, A., Godkin, A., Tissot, A. C., Plückthun, A., Elliott, T., Hengartner, H., & Zinkernagel, R. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.9.1383 · Cited by 763
HUMAN CYTOTOXIC T LYMPHOCYTE RESPONSES TO EPSTEIN-BARR VIRUS INFECTION
Rickinson, A. B., & Moss, D. J. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.405 · Cited by 747
Pitcher, C. J., Quittner, C., Peterson, D. M., Connors, M., Koup, R. A., Maino, V. C., & Picker, L. J. (1999) · Nature Medicine · doi:10.1038/8400 · Cited by 746
HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
Rowland-Jones, S., Sutton, J., Ariyoshi, K., Dong, T., Gotch, F., McAdam, S., Whitby, D., Sabally, S., Gallimore, A., Corrah, T., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-59 · Cited by 740
Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection
Price, D. A., Goulder, P. J. R., Klenerman, P., Sewell, A. K., Easterbrook, P. J., Troop, M., Bangham, C. R. M., & Phillips, R. E. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.5.1890 · Cited by 688
Self-citationWills, M. R., Carmichael, A. J., Mynard, K., Jin, X., Weekes, M. P., Plachter, B., & Sissons, J. G. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7569-7579.1996 · Cited by 688
Janssen, R. S. (1998) · JAMA · doi:10.1001/jama.280.1.42 · Cited by 687
Allen, T. M., O'Connor, D. H., Jing, P., Dzuris, J. L., Mothé, B. R., Vogel, T. U., Dunphy, E., Liebl, M. E., Emerson, C., Wilson, N., et al. (2000) · Nature · doi:10.1038/35030124 · Cited by 680
Zinkernagel, R. M. (1996) · Science · doi:10.1126/science.271.5246.173 · Cited by 651
Rapid Effector Function in CD8+ Memory T Cells
Lalvani, A., Brookes, R., Hambleton, S., Britton, W. J., Hill, A. V. S., & McMichael, A. J. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.6.859 · Cited by 644
Klein, M. R., van Baalen, C. A., Holwerda, A. M., Kerkhof Garde, S. R., Bende, R. J., Keet, I. P., Eeftinck-Schattenkerk, J. K., Osterhaus, A. D., Schuitemaker, H., & Miedema, F. (1995) · The Journal of experimental medicine · doi:10.1084/jem.181.4.1365 · Cited by 638
Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
Ruppert, J., Sidney, J., Celis, E., Kubo, R. T., Grey, H. M., & Sette, A. (1993) · Cell · doi:10.1016/0092-8674(93)90472-3 · Cited by 628
THE IMMUNOGENETICS OF HUMAN INFECTIOUS DISEASES
Hill, A. V. S. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.593 · Cited by 581
Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus
YAP, K. L., ADA, G. L., & MCKENZIE, I. F. C. (1978) · Nature · doi:10.1038/273238a0 · Cited by 520
A Re-Evaluation of the Frequency of CD8+ T Cells Specific for EBV in Healthy Virus Carriers
Tan, L. C., Gudgeon, N., Annels, N. E., Hansasuta, P., O’Callaghan, C. A., Rowland-Jones, S., McMichael, A. J., Rickinson, A. B., & Callan, M. F. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1827 · Cited by 499
Altfeld, M., Rosenberg, E. S., Shankarappa, R., Mukherjee, J. S., Hecht, F. M., Eldridge, R. L., Addo, M. M., Poon, S. H., Phillips, M. N., Robbins, G. K., et al. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.193.2.169 · Cited by 385
Self-citationKoenig, S., Conley, A. J., Brewah, Y. A., Jones, G. M., Leath, S., Boots, L. J., Davey, V., Pantaleo, G., Demarest, J. F., Carter, C., et al. (1995) · Nature Medicine · doi:10.1038/nm0495-330 · Cited by 377
Kalams, S. A., Buchbinder, S. P., Rosenberg, E. S., Billingsley, J. M., Colbert, D. S., Jones, N. G., Shea, A. K., Trocha, A. K., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6715-6720.1999 · Cited by 369
Self-citationMaini, M. K., Boni, C., Ogg, G. S., King, A. S., Reignat, S., Lee, C. K., Larrubia, J. R., Webster, G. J. M., McMichael, A. J., Ferrari, C., et al. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70289-1 · Cited by 366
Lyles, R. H., Muñoz, Á., Yamashita, T. E., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315339 · Cited by 362
Steven, N. M., Annels, N. E., Kumar, A., Leese, A. M., Kurilla, M. G., & Rickinson, A. B. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.9.1605 · Cited by 350
Antigenic oscillations and shifting immunodominance in HIV-1 infections
Nowak, M. A., May, R. M., Phillips, R. E., Rowland-Jones, S., Lalloo, D. G., McAdam, S., Klenerman, P., Köppe, B., Sigmund, K., Bangham, C. R. M., et al. (1995) · Nature · doi:10.1038/375606a0 · Cited by 316
Lechner, F., Gruener, N. H., Urbani, S., Uggeri, J., Santantonio, T., Kammer, A. R., Cerny, A., Phillips, R., Ferrari, C., Pape, G. R., et al. (2000) · European Journal of Immunology · doi:10.1002/1521-4141(200009)30:9<2479::aid-immu2479>3.0.co;2-b · Cited by 312
Kalams, S. A., Goulder, P. J., Shea, A. K., Jones, N. G., Trocha, A. K., Ogg, G. S., & Walker, B. D. (1999) · Journal of Virology · doi:10.1128/jvi.73.8.6721-6728.1999 · Cited by 308
Self-citationPantaleo, G., Demarest, J. F., Schacker, T., Vaccarezza, M., Cohen, O. J., Daucher, M., Graziosi, C., Schnittman, S. S., Quinn, T. C., Shaw, G. M., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.1.254 · Cited by 273
Self-citationGray, C. M., Lawrence, J., Schapiro, J. M., Altman, J. D., Winters, M. A., Crompton, M., Loi, M., Kundu, S. K., Davis, M. M., & Merigan, T. C. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.3.1780 · Cited by 270
Gallimore, A. (1998) · Journal of Experimental Medicine · doi:10.1084/jem.187.10.1647 · Cited by 259
HLA-A11 Epitope Loss Isolates of Epstein-Barr Virus From a Highly A11 + Population
de Campos-Lima, P.-O., Gavioli, R., Zhang, Q.-J., Wallace, L. E., Dolcetti, R., Rowe, M., Rickinson, A. B., & Masucci, M. G. (1993) · Science · doi:10.1126/science.7682013 · Cited by 252
Efficient lysis of human immunodeficiency virus type 1-infected cells by cytotoxic T lymphocytes
Yang, O. O., Kalams, S. A., Rosenzweig, M., Trocha, A., Jones, N., Koziel, M., Walker, B. D., & Johnson, R. P. (1996) · Journal of Virology · doi:10.1128/jvi.70.9.5799-5806.1996 · Cited by 219
Self-citationAntigen processing in vivo and the elicitation of primary CTL responses.
Restifo, N. P., Bacík, I., Irvine, K. R., Yewdell, J. W., McCabe, B. J., Anderson, R. W., Eisenlohr, L. C., Rosenberg, S. A., & Bennink, J. R. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.9.4414 · Cited by 217
Simian immunodeficiency virus-specific CD8+ lymphocyte response in acutely infected rhesus monkeys
Yasutomi, Y., Reimann, K. A., Lord, C. I., Miller, M. D., & Letvin, N. L. (1993) · Journal of Virology · doi:10.1128/jvi.67.3.1707-1711.1993 · Cited by 216
Tsomides, T. J., Aldovini, A., Johnson, R. P., Walker, B. D., Young, R. A., & Eisen, H. N. (1994) · The Journal of experimental medicine · doi:10.1084/jem.180.4.1283 · Cited by 211
Self-citationKlotman, M. E., Kim, S., Buchbinder, A., DeRossi, A., Baltimore, D., & Wong-Staal, F. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.11.5011 · Cited by 197
Johnson, R. P., Trocha, A., Yang, L., Mazzara, G. P., Panicali, D. L., Buchanan, T. M., & Walker, B. D. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.5.1512 · Cited by 185
Self-citationvan der Most, R. G., Sette, A., Oseroff, C., Alexander, J., Murali-Krishna, K., Lau, L. L., Southwood, S., Sidney, J., Chesnut, R. W., Matloubian, M., et al. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.157.12.5543 · Cited by 181
Goulder, P. J. R., Sewell, A. K., Lalloo, D. G., Price, D. A., Whelan, J. A., Evans, J., Taylor, G. P., Luzzi, G., Giangrande, P., Phillips, R. E., et al. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.185.8.1423 · Cited by 180
Self-citationBrander, C., Hartman, K. E., Piechocka‐Trocha, A., Jones, N. G., Johnson, R. P., Korber, B., Wentworth, P. A., Buchbinder, S., Wolinsky, S. M., Walker, B. D., et al. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2405 · Cited by 153
Self-citationBetts, M. R., Casazza, J. P., Patterson, B. A., Waldrop, S. L., Trigona, W. L., Fu, T., Kern, F., Picker, L. J., & Koup, R. A. (2000) · Journal of Virology · doi:10.1128/jvi.74.19.9144-9151.2000 · Cited by 150
Weak anti-HIV CD8+ T-cell effector activity in HIV primary infection
Dalod, M., Dupuis, M., Deschemin, J., Goujard, C., Deveau, C., Meyer, L., Ngo‐Giang‐Huong, N., Rouzioux, C., Guillet, J., Delfraissy, J., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7162 · Cited by 140
Goulder, P., Tang, Y., Brander, C., Betts, M. R., Altfeld, M. A., Annamalai, K., Piechocka‐Trocha, A., He, S., Rosenberg, E. S., Ogg, G. S., et al. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1819 · Cited by 135
Self-citationGoulder, P., Brander, C., Annamalai, K., Mngqundaniso, N., Govender, U., Tang, Y., He, S., Hartman, K. E., O’Callaghan, C. A., Ogg, G. S., et al. (2000) · Journal of Virology · doi:10.1128/jvi.74.12.5679-5690.2000 · Cited by 126
Self-citationO'Callaghan, C. A., Byford, M. F., Wyer, J. R., Willcox, B. E., Jakobsen, B. K., McMichael, A. J., & Bell, J. I. (1999) · Analytical Biochemistry · doi:10.1006/abio.1998.2930 · Cited by 125
Altfeld, M. A., Livingston, B. D., Reshamwala, N., Nguyen, P., Addo, M. M., Shea, A. K., Newman, M. J., Fikes, J. D., Sidney, J., Wentworth, P. A., et al. (2001) · Journal of Virology · doi:10.1128/jvi.75.3.1301-1311.2001 · Cited by 93
Self-citationJin, X., Demoitié, M., Donahoe, S. M., Ogg, G. S., Bonhoeffer, S., Kakimoto, W. M., Gillespie, G. M. A., Moss, P. A. H., Dyer, W. B., Kurilla, M. G., et al. (2000) · The Journal of Infectious Diseases · doi:10.1086/315201 · Cited by 63
Sewell, A. K., Harcourt, G., Goulder, P., Price, D. A., & Phillips, R. E. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270929 · Cited by 62
Self-citationBrander, C., Yang, O. O., Jones, N. G., Lee, Y. J., Goulder, P., Johnson, R. P., Piechocka‐Trocha, A., COLBERT, D. W., Hay, C. M., Buchbinder, S., et al. (1999) · Journal of Virology · doi:10.1128/jvi.73.12.10191-10198.1999 · Cited by 43
Self-citationKlenerman, P., & Zinkernagel, R. M. (1997) · Immunological Reviews · doi:10.1111/j.1600-065x.1997.tb01003.x · Cited by 36
Potential underestimation of HLA-C-restricted cytotoxic T-lymphocyte responses
Goulder, P., Bunce, M., Luzzi, G. A., Phillips, R. E., & McMichael, A. (1997) · AIDS · doi:10.1097/00002030-199715000-00016 · Cited by 22
Self-citation
Cited by
Migueles, S. A., Laborico, A. C., Shupert, W. L., Sabbaghian, M. S., Rabin, R., Hallahan, C. W., Baarle, D. V., Kostense, S., Miedema, F., McLaughlin, M., et al. (2002) · Nature Immunology · doi:10.1038/ni845 · Cited by 1,005
HIV evolution: CTL escape mutation and reversion after transmission
Leslie, A. J., Pfafferott, K. J., Chetty, P., Draenert, R., Addo, M. M., Feeney, M., Tang, Y., Holmes, E. C., Allen, T., Prado, J. G., et al. (2004) · Nature Medicine · doi:10.1038/nm992 · Cited by 847
Self-citationBetts, M. R., Ambrozak, D. R., Douek, D. C., Bonhoeffer, S., Brenchley, J. M., Casazza, J. P., Koup, R. A., & Picker, L. J. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.11983-11991.2001 · Cited by 689
Evolution and transmission of stable CTL escape mutations in HIV infection
Goulder, P. J. R., Brander, C., Tang, Y., Tremblay, C., Colbert, R. A., Addo, M. M., Rosenberg, E. S., Nguyen, T., Allen, R., Trocha, A., et al. (2001) · Nature · doi:10.1038/35085576 · Cited by 543
Self-citationHIV and SIV CTL escape: implications for vaccine design
Goulder, P. J. R., & Watkins, D. I. (2004) · Nature Reviews Immunology · doi:10.1038/nri1417 · Cited by 500
Self-citation
Metadata
- Authors
- Goulder, P. J. R., Altfeld, M. A., Rosenberg, E. S., Nguyen, T., Tang, Y., Eldridge, R. L., Addo, M. M., He, S., Muckerjee, J. S., Phillips, M. N., Bunce, M., Kalams, S. A., Sekaly, R. P., Walker, B. D., & Brander, C.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2001-01-08
- Volume
- 193
- Issue
- 2
- Pages
- 181-194
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2112601022
- Cited by
- 255
- References
- 73
- FWCI
- 11.51
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.